Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,912 papers from all fields of science
Search
Sign In
Create Free Account
fowlpox-TRICOM vaccine
Known as:
Recombinant Fowlpox-TRICOM
, rF-TRICOM (B7.1.iCAM1-LFA3-Fowlpox)
, Recombinant Fowlpox-TRICOM Vaccine
Expand
A vaccine comprised of a recombinant fowlpox virus vector encoding a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM), which may…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Cytotoxic T-Lymphocytes
Gene Expression Regulation
T-Cell Activation
fowlpox-CEA-TRICOM vaccine
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
MP72-10 PHASE I STUDY OF INTRAVESICAL RECOMBINANT FOWLPOX-GM-CSF (RF-GM-CSF) OR RECOMBINANT FOWLPOX-TRICOM (RF-TRICOM) IN PATIENTS WITH BLADDER CARCINOMA PRIOR TO UNDERGOING CYSTECTOMY
R. Weiss
,
M. Stein
,
+4 authors
E. Lattime
2015
Corpus ID: 71608487
2011
2011
Intraprostatic vaccine administration in patients with locally recurrent prostate cancer.
C. Heery
,
Peter Pinto
,
+7 authors
J. Gulley
Journal of Clinical Oncology
2011
Corpus ID: 495734
141 Background: PSA-TRICOM is a cancer vaccine consisting of recombinant poxviruses with transgenes for PSA and 3 T cell…
Expand
2011
2011
Intraprostatic PSA-TRICOM vaccine administration in patients with locally recurrent prostate cancer.
C. Heery
,
P. Pinto
,
+7 authors
J. Gulley
Journal of Clinical Oncology
2011
Corpus ID: 24514659
2530 Background: PSA-TRICOM is a cancer vaccine composed of recombinant poxviruses with transgenes for PSA and 3 T cell…
Expand
Review
2010
Review
2010
A year of successful cancer vaccines points to a path forward.
M. Morse
,
M. Whelan
Current opinion in molecular therapeutics (Print)
2010
Corpus ID: 33090910
Results from recent clinical trials of the therapeutic vaccines sipuleucel-T (Dendreon Corp), PROSTVAC-VF-TRICOM (National Cancer…
Expand
Review
2010
Review
2010
Therapeutic vaccines for prostate cancer.
E. Cha
,
L. Fong
Current opinion in molecular therapeutics (Print)
2010
Corpus ID: 44657086
Although androgen deprivation is the standard of care for advanced prostate cancer, patients with metastatic disease eventually…
Expand
2005
2005
Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesothelioma
P. Triozzi
,
W. Aldrich
,
K. Allen
,
Jose Lima
,
D. Shaw
,
T. Strong
International Journal of Cancer
2005
Corpus ID: 10895875
Deficiency in costimulatory molecule expression has been implicated in the ability of tumors to escape immune effectors. The…
Expand
2003
2003
Clinical protocol. Intra-Lesional rF-B7.1 versus rF-TRICOM vaccine in the treatment of metastatic cancer.
H. Kaufman
,
K. Cheung
,
+5 authors
K. Spanknebel
Human Gene Therapy
2003
Corpus ID: 29821637
2001
2001
Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules.
J. Hodge
,
D. Grosenbach
,
A. N. Rad
,
M. Giuliano
,
H. Sabzevari
,
J. Schlom
Vaccine
2001
Corpus ID: 23037607
2001
2001
A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma.
H. Kaufman
,
G. Deraffele
,
+4 authors
M. Voulo
Human Gene Therapy
2001
Corpus ID: 7654263
2001
2001
Technology evaluation: CEA-TRICOM, Therion Biologics Corp.
M. Morse
Current opinion in molecular therapeutics (Print)
2001
Corpus ID: 37668406
Therion Biologics, the NCI and Aventis Pasteur are investigating CEA-TRICOM, a recombinant, pox virus-based vaccine that…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE